Shanghai Haohai Biological Technology Co Ltd
SSE:688366

Watchlist Manager
Shanghai Haohai Biological Technology Co Ltd Logo
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Watchlist
Price: 62.46 CNY -6.09% Market Closed
Market Cap: 12B CNY
Have any thoughts about
Shanghai Haohai Biological Technology Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Shanghai Haohai Biological Technology Co Ltd

Current Assets 3.7B
Cash & Short-Term Investments 2.7B
Receivables 406.1m
Other Current Assets 576m
Non-Current Assets 3.5B
Long-Term Investments 612.4m
PP&E 1.7B
Intangibles 1.2B
Other Non-Current Assets 63.6m
Current Liabilities 808.3m
Accounts Payable 65m
Accrued Liabilities 185.6m
Short-Term Debt 26m
Other Current Liabilities 531.8m
Non-Current Liabilities 745.7m
Long-Term Debt 193.2m
Other Non-Current Liabilities 552.5m

Balance Sheet
Shanghai Haohai Biological Technology Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
2 010
1 797
1 443
3 223
3 093
2 901
2 542
2 740
Cash
0
0
1
1
1
0
559
2 740
Cash Equivalents
2 010
1 797
1 442
3 222
3 092
2 900
1 983
0
Short-Term Investments
0
0
0
8
22
11
7
20
Total Receivables
338
391
492
392
345
390
428
398
Accounts Receivables
235
330
385
382
334
371
382
328
Other Receivables
103
61
108
10
12
19
46
70
Inventory
118
175
198
240
255
355
485
526
Other Current Assets
21
22
160
82
95
56
71
66
Total Current Assets
2 487
2 385
2 293
3 945
3 810
3 713
3 532
3 750
PP&E Net
463
637
726
939
1 037
1 241
1 401
1 548
PP&E Gross
463
637
726
939
1 037
1 241
1 401
1 548
Accumulated Depreciation
122
149
187
249
327
431
532
637
Intangible Assets
327
491
468
614
579
783
784
729
Goodwill
292
332
332
334
386
407
411
413
Long-Term Investments
64
186
592
298
456
723
671
607
Other Long-Term Assets
59
78
26
23
32
84
93
59
Other Assets
292
332
332
334
386
407
411
413
Total Assets
3 693
N/A
4 109
+11%
4 436
+8%
6 152
+39%
6 299
+2%
6 950
+10%
6 892
-1%
7 105
+3%
Liabilities
Accounts Payable
20
39
37
37
28
46
55
55
Accrued Liabilities
63
60
70
72
68
94
224
197
Short-Term Debt
27
19
23
5
79
49
5
10
Current Portion of Long-Term Debt
32
61
94
20
9
17
29
207
Other Current Liabilities
394
299
228
226
250
281
198
248
Total Current Liabilities
536
478
451
360
434
487
511
716
Long-Term Debt
0
18
16
24
20
39
84
191
Deferred Income Tax
84
126
127
111
102
158
164
162
Minority Interest
82
185
224
199
244
347
388
367
Other Liabilities
88
102
6
4
8
205
231
19
Total Liabilities
789
N/A
909
+15%
825
-9%
697
-15%
808
+16%
1 237
+53%
1 378
+11%
1 455
+6%
Equity
Common Stock
160
160
160
178
177
176
174
171
Retained Earnings
973
1 259
1 638
1 936
2 046
2 399
2 458
2 818
Additional Paid In Capital
1 770
1 770
1 770
3 282
3 260
3 091
3 003
2 981
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
104
Treasury Stock
0
0
0
0
28
0
74
248
Other Equity
1
12
43
60
36
48
47
32
Total Equity
2 904
N/A
3 201
+10%
3 612
+13%
5 455
+51%
5 491
+1%
5 713
+4%
5 515
-3%
5 650
+2%
Total Liabilities & Equity
3 693
N/A
4 109
+11%
4 436
+8%
6 152
+39%
6 299
+2%
6 950
+10%
6 892
-1%
7 105
+3%
Shares Outstanding
Common Shares Outstanding
160
160
160
178
177
246
244
234

See Also

Discover More